The epidermal growth factor receptor is a transmembrane protein that is a receptor for members of the epidermal growth factor family of extracellular protein ligands. From Wikipedia
Phase II trial results presented at AACR 2025 confirm significant improvements in rash severity and quality of life without compromising cancer treatment efficacy.
